BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26513216)

  • 1. Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation.
    Hlavaty KA; McCarthy DP; Saito E; Yap WT; Miller SD; Shea LD
    Biomaterials; 2016 Jan; 76():1-10. PubMed ID: 26513216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation.
    Bryant J; Hlavaty KA; Zhang X; Yap WT; Zhang L; Shea LD; Luo X
    Biomaterials; 2014 Oct; 35(31):8887-8894. PubMed ID: 25066477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4
    Vendomèle J; Dehmani S; Khebizi Q; Galy A; Fisson S
    Front Immunol; 2018; 9():504. PubMed ID: 29662488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early regulation of CD8 T cell alloreactivity by CD4+CD25- T cells in recipients of anti-CD154 antibody and allogeneic BMT is followed by rapid peripheral deletion of donor-reactive CD8+ T cells, precluding a role for sustained regulation.
    Fehr T; Takeuchi Y; Kurtz J; Wekerle T; Sykes M
    Eur J Immunol; 2005 Sep; 35(9):2679-90. PubMed ID: 16082727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplantation tolerance induced by intranasal administration of HY peptides.
    Chai JG; James E; Dewchand H; Simpson E; Scott D
    Blood; 2004 May; 103(10):3951-9. PubMed ID: 14726386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flt3-L augments the engraftment of donor-derived bone marrow cells when combined with sublethal irradiation and costimulatory (CD28/B7 and CD40/CD40L) blockade.
    Woodward JE; Salam A; Logar AJ; Schaefer AT; Rao AS
    Cell Transplant; 2002; 11(2):147-59. PubMed ID: 12099638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8 T cell of donor splenocyte mixed with bone marrow cells is more effective than CD4 T cell for induction of donor-specific tolerance in sublethally irradiated mice.
    Yoshida A; Narumi S; Hashimoto N; Itabashi Y; Hakamada K; Sasaki M
    Transplant Proc; 2004 Oct; 36(8):2418-22. PubMed ID: 15561266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment.
    Wekerle T; Kurtz J; Ito H; Ronquillo JV; Dong V; Zhao G; Shaffer J; Sayegh MH; Sykes M
    Nat Med; 2000 Apr; 6(4):464-9. PubMed ID: 10742157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-intensity transplant regimens facilitate recruitment of donor-specific regulatory T cells that promote hematopoietic engraftment.
    Weng L; Dyson J; Dazzi F
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8415-20. PubMed ID: 17494756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model.
    Shah S; Daneshmandi S; Hughes KR; Yu S; Bedoya AM; Shea LD; Luo X
    Biomaterials; 2019 Jul; 210():70-82. PubMed ID: 31077862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minor Antigen Disparities Impede Induction of Long Lasting Chimerism and Tolerance through Bone Marrow Transplantation with Costimulation Blockade.
    Bigenzahn S; Pree I; Klaus C; Pilat N; Mahr B; Schwaiger E; Nierlich P; Wrba F; Wekerle T
    J Immunol Res; 2016; 2016():8635721. PubMed ID: 27872868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of host effector memory CD8+ T cells in marrow rejection after mixed chimerism induction in cynomolgus monkeys.
    Setoguchi K; Kishimoto H; Kobayashi S; Shimmura H; Ishida H; Toki D; Suzuki T; Ohnuki K; Tate Y; Fujioka S; Abe R; Tanabe K
    Transpl Immunol; 2010 Aug; 23(4):194-203. PubMed ID: 20624462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone.
    Eljaafari A; Yuruker O; Ferrand C; Farre A; Addey C; Tartelin ML; Thomas X; Tiberghien P; Simpson E; Rigal D; Scott D
    J Immunol; 2013 Jan; 190(1):184-94. PubMed ID: 23225889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.
    Prasad S; Neef T; Xu D; Podojil JR; Getts DR; Shea LD; Miller SD
    J Autoimmun; 2018 May; 89():112-124. PubMed ID: 29258717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.